Affiliation:
1. Shahid Beheshti University of Medical Sciences
Abstract
Abstract
Objectives
Drug-related problems (DRPs) are adverse events or circumstances that interfere with favorable health outcomes. Medication therapy management (MTM) was developed to detect and manage DRP. This study set out to identify DRP-associated factors and reporting of subsequent interventions in a university-affiliated educational pharmacy.
Methods
This study was conducted from January 2020 to December 2022 at Shahid Kazemi Pharmacy, a large referral community pharmacy in Tehran, Iran. After medication review and complete medical history collection, DRPs were identified classified, and necessary interventions were performed. Medication adherence and satisfaction were evaluated before and 2–4 weeks after providing the MTM services.
Results
Within 1432 admissions, 838 patients were included and received 1116 interventions. Among the 1116 DRPs detected, the most common were drug information (27.4%), difficulty using dosage forms (26.3%), and any toxicity, allergic reaction, or adverse effects related to medications (12.8%). A significant association was detected between the number of DRPs and the age, the number of medications, and underlying chronic diseases (P < 0.05). Adjusting the age association of the number of medications and the number of underlying chronic diseases remained significant. The use of medications related to the alimentary tract and metabolism, medications affecting the blood and hematopoietic organs, medications affecting the cardiovascular system, antineoplastic and immunomodulatory medications, and medications affecting the nervous system were significantly associated with a higher risk for the occurrence of DRPs (P < 0.05).
Conclusions
Community pharmacy-led MTM services have a significant impact on DRP detection, management, medication adherence, and pharmacotherapy satisfaction.
Publisher
Research Square Platform LLC
Reference38 articles.
1. Strand LM, Cipolle RJ, Morley PC, Frakes MJ. The Impact of Pharmaceutical Care Practice on the Practitioner and the Patient i n the Ambulatory Practice Setting: T wenty-five Years of Experience. 2004;3987–4001.
2. Good pharmacy. practice (GPP) in community and hospital settings [Internet]. [cited 2022 Feb 11]. Available from: https://apps.who.int/iris/handle/10665/63097.
3. Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Drug-related problems and associated variables;Wuyts J;Res Soc Adm Pharm,2020
4. Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital;Jourdan JP;Int J Clin Pharm [Internet],2018
5. Medicare part D [6];Macdonald K;Am J Nurs,2006